| 100763-2 | Mycobacterium sp comparative reaction interpretation Narrative |
| 100764-0 | Mycobacterium bovis reaction wheal Qualitative --3 days post dose mammalian tuberculin intradermal (qualitative) |
| 100968-7 | Bovine tuberculosis comparative cervical test panel - Skin |
| 10178-2 | History of Skin disorders Narrative |
| 10206-1 | Physical findings of Skin Narrative |
| 105745-4 | Enterovirus RNA in Skin (qualitative, naa with probe detection) |
| 105746-2 | Herpes virus 6 DNA in Skin (qualitative, naa with probe detection) |
| 106044-1 | Methicillin resistant Staphylococcus aureus in Skin (qualitative, organism specific culture) |
| 10700-3 | Orthopoxvirus in Skin (electron microscopy) |
| 107177-8 | Mycobacterium sp identified in Skin (organism specific culture) |
| 10734-2 | Varicella zoster virus identified in Skin (electron microscopy) |
| 108097-7 | Monkeypox virus DNA in Skin (qualitative, naa with probe detection) |
| 108661-0 | Vesicular stomatitis virus Ag in Skin |
| 108662-8 | Swine vesicular disease virus Ag in Skin |
| 108663-6 | Herpes simplex virus Ag in Skin |
| 112395-9 | Treponema pallidum DNA in Skin (qualitative, naa with probe detection) |
| 112396-7 | Haemophilus ducreyi DNA in Skin (qualitative, naa with probe detection) |
| 112397-5 | Cytomegalovirus DNA in Skin (qualitative, naa with probe detection) |
| 112398-3 | Chlamydia trachomatis L1+L2+L3 DNA in Skin (qualitative, naa with probe detection) |
| 14482-4 | Diphtheria identified in Skin (organism specific culture) |
| 14525-0 | Rubella virus Ag in Skin (qualitative, immunofluorescence) |
| 14536-7 | Measles virus Ag in Skin (qualitative, immunofluorescence) |
| 14547-4 | Mumps virus Ag in Skin (qualitative, immunofluorescence) |
| 1647-7 | Tuberculosis reaction wheal --3 days post 25 TU intradermal |
| 1648-5 | Tuberculosis reaction wheal --3 days post 5 TU intradermal |
| 16640-5 | Coccidioides reaction wheal |
| 22941-9 | Brucella reaction wheal --2 days post 0.1 mL brucellin intradermal |
| 22942-7 | Brucella reaction wheal --3 days post 0.1 mL brucellin intradermal |
| 22960-9 | Burkholderia mallei reaction -1D post 0.1 mL mallein intradermal- |
| 22961-7 | Burkholderia mallei reaction -2D post 0.1 mL mallein intradermal- |
| 23025-0 | Dermatophilus congolensis in Skin (qualitative, giemsa stain) |
| 23136-5 | Histoplasma capsulatum farciminosum reaction wheal --1 day post dose intradermal |
| 23137-3 | Histoplasma capsulatum farciminosum reaction wheal --2 days post dose intradermal |
| 23138-1 | Histoplasma capsulatum farciminosum reaction wheal --3 days post dose intradermal |
| 23151-4 | Leishmania reaction wheal --3 days post 0.1 mL leishmanin intradermal |
| 23232-2 | Mite identified in Skin (flotation) |
| 23233-0 | Mite identified in Skin (parasite sedimentation) |
| 23310-6 | Myxoma virus Ag in Skin (qualitative, immune diffusion (id)) |
| 23339-5 | Paratuberculosis reaction wheal --3 days post 0.1 mL avian tuberculin intradermal |
| 23340-3 | Paratuberculosis reaction wheal --3 days post 0.1 mL johnin intradermal |
| 23445-0 | Swine vesicular disease virus Ag in Skin (qualitative, complement fixation) |
| 23447-6 | Swine vesicular disease virus Ag in Skin (qualitative, immunoassay) |
| 23506-9 | Tritrichomonas foetus reaction wheal --post 0.1 mL tricin intradermal |
| 23537-4 | Tuberculosis reaction wheal --2 days post dose mammalian tuberculin intradermal |
| 23538-2 | Tuberculosis reaction wheal --3 days post dose avian tuberculin intradermal |
| 23539-0 | Tuberculosis reaction wheal --3 days post dose mammalian tuberculin intradermal |
| 23557-2 | Vesicular stomatitis virus Ag in Skin (qualitative, immunoassay) |
| 23559-8 | Vesicular stomatitis virus Ag in Skin (qualitative, complement fixation) |
| 23752-9 | Mite identified in Skin |
| 28187-3 | Peripheral alteration (qualitative) |
| 28207-9 | Skin incision (qualitative) |
| 28208-7 | Skin integrity impairment (qualitative) |
| 28209-5 | Skin integrity impairment risk (qualitative) |
| 28526-2 | Skin integrity alteration (qualitative) |
| 30203-4 | Candida albicans reaction wheal --2 days post 0.1 mL Candida albicans intradermal |
| 30210-9 | Coccidioides reaction wheal --2 days post 0.1 mL coccidioidin intradermal |
| 30227-3 | Histoplasma capsulatum farciminosum reaction wheal --2 days post 0.1 mL histoplasmin intradermal |
| 30228-1 | Mumps reaction wheal --2 days post 0.1 mL mumps intradermal |
| 30232-3 | Trichophyton reaction wheal --2 days post 0.1ml trichophyton intradermal |
| 31847-7 | Herpes simplex virus 1 Ag in Skin (qualitative) |
| 31850-1 | Herpes simplex virus 2 Ag in Skin (qualitative) |
| 31854-3 | Herpes simplex virus Ag in Skin (qualitative) |
| 31882-4 | Measles virus Ag in Skin (qualitative) |
| 31895-6 | Mumps virus Ag in Skin (qualitative) |
| 31961-6 | Rubella virus Ag in Skin (qualitative) |
| 31972-3 | Swine vesicular disease virus Ag in Skin (qualitative) |
| 31981-4 | Varicella zoster virus Ag in Skin (qualitative) |
| 31985-5 | Vesicular stomatitis virus Ag in Skin (qualitative) |
| 32187-7 | Microscopic observation in Skin (tzanck smear) |
| 32475-6 | Physical findings skin pressure injury |
| 32557-1 | Candida albicans reaction wheal --1 day post 50 ug Candida albicans intradermal |
| 32558-9 | Mumps reaction wheal --1 day post 0.1 mL mumps intradermal |
| 32560-5 | Trichophyton reaction wheal --2 days post 50 ug trichophyton intradermal |
| 32561-3 | Tuberculosis reaction wheal --1 day post dose mammalian tuberculin intradermal |
| 32567-0 | Candida albicans reaction wheal --2 days post 50 ug Candida albicans intradermal |
| 32568-8 | Trichophyton reaction wheal --1 day post 50 ug trichophyton intradermal |
| 38222-6 | Sensory perception Braden scale (qualitative) |
| 38226-7 | Friction and shear Braden scale (qualitative) |
| 38229-1 | Moisture exposure Braden scale (qualitative) |
| 39104-5 | Appearance of Skin Narrative |
| 39105-2 | Appearance of Skin |
| 39106-0 | Temperature of Skin |
| 39107-8 | Color of Skin |
| 39109-4 | Turgor of Skin |
| 39110-2 | Protection of Skin |
| 39129-2 | Moisture of Skin |
| 41176-9 | Trichophyton reaction wheal --2 days post dose trichophyton intradermal |
| 41177-7 | Trichophyton reaction wheal --1 day post dose trichophyton intradermal |
| 41178-5 | Mumps reaction wheal --2 days post dose mumps intradermal |
| 41179-3 | Mumps reaction wheal --1 day post dose mumps intradermal |
| 41180-1 | Candida albicans reaction wheal --2 days post Candida albicans intradermal |
| 41181-9 | Candida albicans reaction wheal --1 day post Candida albicans intradermal |
| 41182-7 | Histoplasma capsulatum farciminosum reaction wheal --2 days post histoplasmin intradermal |
| 43419-1 | Tuberculosis reaction wheal --3 days post 1 TU intradermal |
| 43693-1 | Varicella zoster virus identified in Skin (shell vial culture) |
| 44464-6 | Herpes simplex virus 1 in Skin (qualitative, organism specific culture) |
| 44486-9 | Herpes simplex virus 2 in Skin (qualitative, organism specific culture) |
| 44582-5 | IgA in Skin (qualitative, immunofluorescence) |
| 44596-5 | IgG Ag in Skin (qualitative, immunofluorescence) |
| 44697-1 | Lesion size.maximum dimension in Skin |